80
Participants
Start Date
November 29, 2021
Primary Completion Date
October 14, 2025
Study Completion Date
October 14, 2025
ANI
Investigators will attach the ANI monitor V2 (MDoloris Medical Systems, Lille, France) to the patient and monitor Analgesia Nociception Index (ANI) during anesthesia. Remifentanil infusion rate is adjusted according to ANI monitoring. The ANI is adjusted to be between 50 and 70.
Control
Remifentanil infusion rate is adjusted according to the conventional method of blood pressure and heart rate monitroing. Blood pressure and heart rate are controlled to be within 20% of baseline. Investigators will not monitor ANI in this group.
RECRUITING
GangnamSeverance Hospital, Seoul
Gangnam Severance Hospital
OTHER